- Conditions
- Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse, Disease Attributes, +11 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
Clinical trial condition
NK Cell
Explore clinical trials studying NK Cell. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
NK Cell trial results
Recruiting
CD123-CD16-NK Cells Immunotherapy for AML
NCT06835140
- Conditions
- AML (Acute Myelogenous Leukemia), CD123+ Acute Myeloid Leukemia, Hematologic Diseases, +7 more
- Locations
-
- Chinese PLA General Hospital Beijing, China
NCT07579208
- Conditions
- Astrocytoma, Chimera Antigen Receptor (CAR), EGFRvIII, +14 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma
NCT05909098
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, NK Cell
- Locations
-
- EC of Xiangyang No.1 People's Hospital Hubei University of Medicine Hubei, Xiangyang, China